faridabad-

BRIC-Translational Health Science and Technology Institute (BRIC-THSTI), in collaboration with Miltenyi Biotec and the Biotechnology Industry Research Assistance Council (BIRAC), has announced India’s first hands-on training program on the Foundations of Cell and Gene Therapy (CGT) Manufacturing, with a special emphasis on CAR-T cell therapy.

The initiative aims to strengthen India’s translational research and clinical manufacturing capabilities by providing early-career scientists, clinicians and industry professionals with end-to-end exposure to the CGT development pipeline — spanning preclinical workflows, GMP-compliant manufacturing and clinical translation.

Titled “CAR-T Cell Therapy Manufacturing Hands-on Workshop and Symposia,” the three-day program will be held at THSTI, NCR Biotech Science Cluster, from 12–14 November 2025. Participants will first complete an online preparatory module through Miltenyi University, followed by immersive, practical sessions at THSTI’s cell and gene therapy facility.

The training integrates virtual coursework with facility-based learning to deliver comprehensive skill-building in CGT manufacturing. Key components include: